# Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

> **NCT00285012** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 504 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** placebo
- **DRUG:** Varenicline Tartarate

## Key facts

- **NCT ID:** NCT00285012
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-07
- **Final completion:** 2009-04
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2010-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00285012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00285012, "Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00285012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*